As of 2025-11-02, the Relative Valuation of Infinity Pharmaceuticals Inc (INFI) is (22.31) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 USD, the upside of Infinity Pharmaceuticals Inc based on Relative Valuation is -50009.8%.
The range of the Relative Valuation is (21.20) - (22.31) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.8x - 17.7x | 17.7x |
| Forward P/E multiples | 16.8x - 22.4x | 17.7x |
| Fair Price | (21.20) - (22.31) | (22.31) |
| Upside | -47528.4% - -50009.8% | -50009.8% |
| Date | P/E |